Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Role of Mir-192-5p during Response to Azacitidine and Lenalidomide Therapy in Myelodysplastic Syndromes

Matilde Y Follo, Alessia De Stefano, Sara Mongiorgi, Valentina Indio, Annalisa Astolfi, Stefano Ratti, Andrea Pellagatti, Miriam Fogli, Andrea Pession, Michele Cavo, Lucia Manzoli, Lucio Cocco, Jacqueline Boultwood, Sarah Parisi, Stefania Paolini, Carlo Finelli

Blood (2021) 138 (Supplement 1): 3673.

https://doi.org/10.1182/blood-2021-149183

Published: 2021

Journal Articles

Torque teno mini virus as a cause of childhood acute promyelocytic leukemia lacking PML/RARA fusion

Annalisa Astolfi, Riccardo Masetti, Valentina Indio, Salvatore Nicola Bertuccio, Daria Messelodi, Simone Rampelli, Davide Leardini, Matteo Carella, Salvatore Serravalle, Virginia Libri, Jessica Bandini, Stefano Volinia, Marco Candela, Andrea Pession

Blood (2021) 138 (18): 1773–1777.

https://doi.org/10.1182/blood.2021011677

Published: 2021

Includes: Supplemental data

Journal Articles

Sequential Analysis of miRNA Profiling during Azacitidine and Lenalidomide Therapy in Myelodysplastic Syndromes

Matilde Y Follo, PhD, Sara Mongiorgi, PhD, Alessia De Stefano, BSc, Valentina Indio, PhD, Annalisa Astolfi, PhD, Andrea Pellagatti, Stefano Ratti, MD, Miriam Fogli, PhD, Sarah Parisi, MDPhD, Andrea Pession, Michele Cavo, Lucia Manzoli, MD, Lucio Cocco, MD, Jacqueline Boultwood, Carlo Finelli

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-136942

Published: 2020

Journal Articles

Negative Prognostic Relevance of a Specific 3-Gene Cluster in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Blood (2018) 132 (Supplement 1): 4347.

https://doi.org/10.1182/blood-2018-99-112062

Published: 2018

Journal Articles

Gene Mutations and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Matilde Y Follo, PhD, Andrea Pellagatti, PhD, Richard N Armstrong, PhD, Stefano Ratti, MD, Sara Mongiorgi, PhD, Annalisa Astolfi, PhD, Valentina Indio, PhD, Cristina Clissa, MD PhD, Domenico Russo, MD, Marco Gobbi, MD, Marilena Barraco, PhD, Sarah Parisi, MD PhD, Andrea Pession, MD, Michele Cavo, MD, Lucia Manzoli, MD, Lucio Cocco, MD, Jacqueline Boultwood, PhD, Carlo Finelli, MD

Blood (2017) 130 (Supplement 1): 5299.

https://doi.org/10.1182/blood.V130.Suppl_1.5299.5299

Published: 2017

Journal Articles

Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50

Blood (2016) 128 (22): 1702.

https://doi.org/10.1182/blood.V128.22.1702.1702

Published: 2016

Journal Articles

Role of Nuclear Inositide Signalling and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Matilde Follo, PhD, Sara Mongiorgi, PhD, Cristina Clissa, MD, Annalisa Astolfi, PhD, Domenico Russo, MD, Marco Gobbi, MD, Costanza Bosi, MD, Monica Crugnola, MD, Marta Stanzani, MD, Stefano Ratti, MD, Sarah Parisi, MD, Marilena Barraco, PhD, Lucia Manzoli, MD, Andrea Pession, MD, Lucio Cocco, MD, PhD, Carlo Finelli, MD

Blood (2016) 128 (22): 5091.

https://doi.org/10.1182/blood.V128.22.5091.5091

Published: 2016

Journal Articles

Novel Genomic Patterns of Metabolic Remodeling in Acute Myeloid Leukemia

Blood (2015) 126 (23): 3837.

https://doi.org/10.1182/blood.V126.23.3837.3837

Published: 2015

Journal Articles

A Specific Pattern of Somatic Mutations Associates with Poor Prognosis Aneuploid Acute Myeloid Leukemia: Results from the European NGS-PTL Consortium

Blood (2015) 126 (23): 3840.

https://doi.org/10.1182/blood.V126.23.3840.3840

Published: 2015

Journal Articles

NUP98 Fusion Proteins Are Recurrent Aberrancies in Childhood Acute Myeloid Leukemia: A Report from the AIEOP AML-2001-02 Study Group

Valeria Bisio, BS, Martina Pigazzi, PhD, Elena Manara, PhD, Riccardo Masetti, MD, Marco Togni, BS, Annalisa Astolfi, PhD, Cristina Mecucci, MD PhD, Vincenzo Zappavigna, PhD, Valentina Salsi, PhD, Pietro Merli, MD, Carmelo Rizzari, Franca Fagioli, MD, Franco Locatelli, Giuseppe Basso, MD

Blood (2014) 124 (21): 1025.

https://doi.org/10.1182/blood.V124.21.1025.1025

Published: 2014

Journal Articles

Dissecting the Molecular Mechanisms of Aneuploidy in Acute Myeloid Leukemia By Next Generation Sequencing

Blood (2014) 124 (21): 1028.

https://doi.org/10.1182/blood.V124.21.1028.1028

Published: 2014

Journal Articles

CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype

Riccardo Masetti, Martina Pigazzi, Marco Togni, Annalisa Astolfi, Valentina Indio, Elena Manara, Rita Casadio, Andrea Pession, Giuseppe Basso, Franco Locatelli

Blood (2013) 121 (17): 3469–3472.

https://doi.org/10.1182/blood-2012-11-469825

Published: 2013

Journal Articles

Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes

Blood (2011) 117 (13): 3596–3608.

https://doi.org/10.1182/blood-2010-08-301556

Published: 2011

Includes: Supplemental data

Journal Articles

Identification of A Pharmacogenomic Profile Associated with High Sensitivity and Low Toxicity to a Combination of Gemtuzumab Ozogamicin Plus Fludarabine, Cytarabine, Idarubicin Regimen In CD33-Positive Acute Myeloid Leukemia (AML) Patients

Blood (2010) 116 (21): 967.

https://doi.org/10.1182/blood.V116.21.967.967

Published: 2010

Journal Articles

The Elevated Expression of FBP1 , a Key-Enzyme of Gluconeogenesis Gene, Is Associated to High Sokal Risk In Chronic Myeloid Leukemia Patients.

Carolina Terragna, Sandra Durante, Annalisa Astolfi, Francesca Palandri, Fausto Castagnetti, Nicoletta Testoni, Marilina Amabile, Ilaria Iacobucci, Simona Soverini, Giuliana Alimena, MD, Massimo Breccia, MD, Fabrizio Pane, MD, Giuseppe Saglio, MD, PhD, Gianantonio Rosti, Michele Baccarani, Giovanni Martinelli

Blood (2010) 116 (21): 3399.

https://doi.org/10.1182/blood.V116.21.3399.3399

Published: 2010

Journal Articles

Gene Expression Analysis Uncovers Similarity and Differences Among Burkitt Lymphoma Subtypes

Blood (2010) 116 (21): 2494.

https://doi.org/10.1182/blood.V116.21.2494.2494

Published: 2010

Journal Articles

C-Myc Mediated Regulation of Multidrug Resistance Genes in Chronic Myeloid Leukaemia Cd34+ Cell Progenitors.

Samuele Gherardi, Simona Soverini, Ph.D., Nunzio Iraci, Ph.D., Carolina Terragna, Ph.D., Emanuele Valli, Sandra Durante, Annalisa Astolfi, Ph.D., Roberto Bernardoni, Ph.D., Thea Kalebic, MD, Fabrizio Pane, MD, Giuseppe Saglio, MD, Giovanni Martinelli, MD, Michele Baccarani, MD, Giovanni Perini, Ph.D.

Blood (2009) 114 (22): 3252.

https://doi.org/10.1182/blood.V114.22.3252.3252

Published: 2009

Journal Articles

High-Resolution Genome Wide Copy Number Alteration (CNA) and Loss of Heterozigosity (LOH) Analysis in Chronic Myeloid Leukemia (CML) Shows That High and Intermediate Sokal Risk Pts (Pts) Have Multiple Losses Targeting Genes Involved in DNA Repair.

Simona Soverini, PhD, Sabrina Colarossi, Alessandra Gnani, Annalisa Astolfi, Serena Formica, Fausto Castagnetti, Francesca Palandri, Gabriele Gugliotta, Angela Poerio, Ilaria Iacobucci, Marilina Amabile, Giulia Marzocchi, Simona Luatti, Carolina Terragna, Sandra Durante, Nicoletta Testoni, Gianantonio Rosti, Michele Baccarani, Giovanni Martinelli

Blood (2009) 114 (22): 3262.

https://doi.org/10.1182/blood.V114.22.3262.3262

Published: 2009

Journal Articles

Complete Response to First-Line Bortezomib-Thalidomide-Dexamethasone Therapy in Multiple Myeloma Patients with t(4;14): Analysis of Gene Expression Profile.

Blood (2009) 114 (22): 2811.

https://doi.org/10.1182/blood.V114.22.2811.2811

Published: 2009

Journal Articles

Whole-Transcriptome Sequencing of a Chronic Myeloid Leukemia (CML) Patient at Diagnosis and at the Time of Progression to Blast Crisis (BC).

Blood (2009) 114 (22): 4259.

https://doi.org/10.1182/blood.V114.22.4259.4259

Published: 2009

NARROW

Role of Mir-192-5p during Response to Azacitidine and Lenalidomide Therapy in Myelodysplastic Syndromes

Torque teno mini virus as a cause of childhood acute promyelocytic leukemia lacking PML/RARA fusion

Sequential Analysis of miRNA Profiling during Azacitidine and Lenalidomide Therapy in Myelodysplastic Syndromes

Negative Prognostic Relevance of a Specific 3-Gene Cluster in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Gene Mutations and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50

Role of Nuclear Inositide Signalling and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy

Novel Genomic Patterns of Metabolic Remodeling in Acute Myeloid Leukemia

A Specific Pattern of Somatic Mutations Associates with Poor Prognosis Aneuploid Acute Myeloid Leukemia: Results from the European NGS-PTL Consortium

NUP98 Fusion Proteins Are Recurrent Aberrancies in Childhood Acute Myeloid Leukemia: A Report from the AIEOP AML-2001-02 Study Group

Dissecting the Molecular Mechanisms of Aneuploidy in Acute Myeloid Leukemia By Next Generation Sequencing

CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype

Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes

Identification of A Pharmacogenomic Profile Associated with High Sensitivity and Low Toxicity to a Combination of Gemtuzumab Ozogamicin Plus Fludarabine, Cytarabine, Idarubicin Regimen In CD33-Positive Acute Myeloid Leukemia (AML) Patients

The Elevated Expression of FBP1 , a Key-Enzyme of Gluconeogenesis Gene, Is Associated to High Sokal Risk In Chronic Myeloid Leukemia Patients.

Gene Expression Analysis Uncovers Similarity and Differences Among Burkitt Lymphoma Subtypes

C-Myc Mediated Regulation of Multidrug Resistance Genes in Chronic Myeloid Leukaemia Cd34+ Cell Progenitors.

High-Resolution Genome Wide Copy Number Alteration (CNA) and Loss of Heterozigosity (LOH) Analysis in Chronic Myeloid Leukemia (CML) Shows That High and Intermediate Sokal Risk Pts (Pts) Have Multiple Losses Targeting Genes Involved in DNA Repair.

Complete Response to First-Line Bortezomib-Thalidomide-Dexamethasone Therapy in Multiple Myeloma Patients with t(4;14): Analysis of Gene Expression Profile.

Whole-Transcriptome Sequencing of a Chronic Myeloid Leukemia (CML) Patient at Diagnosis and at the Time of Progression to Blast Crisis (BC).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only